Shares of drug-maker Sarepta are higher Tuesday on the back of an upgrade from RBC, but Jim Cramer says he’s not adding shares to his portfolio. Cramer says that while it’s possible that the company could get a takeover offer, he believes the easy money has been made. “I
Subscribe to TheStreetTV on YouTube:
For more content from TheStreet visit:
Check out all our videos:
Follow TheStreet on Twitter:
Like TheStreet on Facebook:
Follow TheStreet on LinkedIn:
Follow TheStreet on Google+:
source
